Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-18 7:57 pm Sale |
2023-01-17 | 13D | Oncorus, Inc. ONCR |
James E. Flynn | 1,015,154 3.910% |
-566,397 (-35.81%) |
Filing History |
| 2023-01-13 6:47 pm Sale |
2023-01-11 | 13D | Oncorus, Inc. ONCR |
James E. Flynn | 1,581,551 6.090% |
-954,635 (-37.64%) |
Filing History |
| 2022-12-30 7:15 pm Sale |
2022-12-22 | 13D | Oncorus, Inc. ONCR |
James E. Flynn | 2,536,186 9.760% |
-470,747 (-15.66%) |
Filing History |
| 2022-12-29 5:27 pm Sale |
2022-12-29 | 13G | Delcath Systems, Inc. DCTH |
James E. Flynn | 0 0.000% |
-500,000 (Position Closed) |
Filing History |
| 2022-12-29 5:25 pm Sale |
2022-12-29 | 13G | Vincerx Pharma, Inc. VINC |
James E. Flynn | 0 0.000% |
-68,966 (Position Closed) |
Filing History |
| 2022-12-29 5:24 pm Sale |
2022-12-29 | 13G | Xilio Therapeutics, Inc. XLO |
James E. Flynn | 0 0.000% |
-2,154,061 (Position Closed) |
Filing History |
| 2022-12-23 3:35 pm Purchase |
2022-12-23 | 13G | Terns Pharmaceuticals, Inc. TERN |
James E. Flynn | 2,851,287 5.940% |
991,287 (+53.30%) |
Filing History |
| 2022-12-21 7:05 pm Purchase |
2022-12-19 | 13D | Oncorus, Inc. ONCR |
James E. Flynn | 3,006,933 11.580% |
157,963 (+5.54%) |
Filing History |
| 2022-12-01 4:51 pm Sale |
2022-11-22 | 13G | Frazier Lifesciences Acquisition Corporation FLAC |
James E. Flynn | 0 0.000% |
-2,572,986 (Position Closed) |
Filing History |
| 2022-11-23 3:19 pm Unchanged |
2022-11-21 | 13D | Graybug Vision, Inc. GRAY |
James E. Flynn | 377,265 24.490% |
0 (Unchanged) |
Filing History |
| 2022-11-18 5:06 pm Purchase |
2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY |
James E. Flynn | 11,077,927 11.810% |
11,077,927 (New Position) |
Filing History |
| 2022-11-18 4:14 pm Purchase |
2022-11-08 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
James E. Flynn | 2,796,261 9.990% |
2,796,261 (New Position) |
Filing History |
| 2022-11-17 4:38 pm Purchase |
2022-11-16 | 13G | Brookdale Senior Living Inc. BKD |
James E. Flynn | 12,216,561 6.540% |
7,941,753 (+185.78%) |
Filing History |
| 2022-11-16 4:47 pm Purchase |
2022-11-07 | 13G | Abeona Therapeutics Inc. ABEO |
James E. Flynn | 1,739,130 5.060% |
1,739,130 (New Position) |
Filing History |
| 2022-11-14 4:45 pm Purchase |
2022-11-04 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
James E. Flynn | 6,060,491 5.820% |
6,060,491 (New Position) |
Filing History |
| 2022-11-14 4:44 pm Purchase |
2022-11-02 | 13G | Frazier Lifesciences Acquisition Corporation FLAC |
James E. Flynn | 2,572,986 17.340% |
2,572,986 (New Position) |
Filing History |
| 2022-11-14 4:42 pm Purchase |
2022-11-03 | 13G | Nuvalent, Inc. NUVL |
James E. Flynn | 25,466,889 39.240% |
690,611 (+2.79%) |
Filing History |
| 2022-10-14 4:51 pm Purchase |
2022-10-10 | 13G | Enhabit, Inc. EHAB |
James E. Flynn | 2,846,000 5.740% |
2,846,000 (New Position) |
Filing History |
| 2022-10-04 4:32 pm Purchase |
2022-10-03 | 13G | IVERIC bio, Inc. ISEE |
James E. Flynn | 6,601,000 5.590% |
1,839,862 (+38.64%) |
Filing History |
| 2022-09-30 3:29 pm Purchase |
2022-09-20 | 13G | Merus N.V. MRUS |
James E. Flynn | 2,521,553 5.500% |
2,521,553 (New Position) |
Filing History |